Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

684 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.
Mazzaschi G, Perrone F, Minari R, Verzè M, Azzoni C, Bottarelli L, Pluchino M, Armillotta MP, Ubaldi A, Altimari A, Gruppioni E, Sperandi F, Andrini E, Guaitoli G, Bettelli S, Longo L, Bertolini F, Barbieri F, Pagano M, Bonelli C, Tagliavini E, Nicoli D, Ubiali A, Zangrandi A, Trubini S, Proietto M, Gnetti L, Tiseo M; DETECTION study group. Mazzaschi G, et al. Among authors: barbieri f. Clin Lung Cancer. 2022 Nov;23(7):e478-e488. doi: 10.1016/j.cllc.2022.07.005. Epub 2022 Jul 25. Clin Lung Cancer. 2022. PMID: 36002369
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.
Perrone F, Mazzaschi G, Minari R, Verzè M, Azzoni C, Bottarelli L, Nizzoli R, Pluchino M, Altimari A, Gruppioni E, Sperandi F, Andrini E, Guaitoli G, Bertolini F, Barbieri F, Bettelli S, Longo L, Pagano M, Bonelli C, Tagliavini E, Nicoli D, Ubiali A, Zangrandi A, Trubini S, Proietto M, Gnetti L, Tiseo M. Perrone F, et al. Among authors: barbieri f. Cancers (Basel). 2022 Apr 16;14(8):2019. doi: 10.3390/cancers14082019. Cancers (Basel). 2022. PMID: 35454926 Free PMC article.
Concomitant EGFR and KRAS mutations in ALK-rearranged lung cancer.
Rossi G, Baldi L, Barbieri F, Bertolini F, Tiseo M. Rossi G, et al. Among authors: barbieri f. Ann Oncol. 2015 May;26(5):1035-1036. doi: 10.1093/annonc/mdv067. Epub 2015 Feb 10. Ann Oncol. 2015. PMID: 25669831 Free article. No abstract available.
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy.
Minari R, Bordi P, Del Re M, Facchinetti F, Mazzoni F, Barbieri F, Camerini A, Comin CE, Gnetti L, Azzoni C, Nizzoli R, Bortesi B, Rofi E, Petreni P, Campanini N, Rossi G, Danesi R, Tiseo M. Minari R, et al. Among authors: barbieri f. Lung Cancer. 2018 Jan;115:21-27. doi: 10.1016/j.lungcan.2017.11.011. Epub 2017 Nov 13. Lung Cancer. 2018. PMID: 29290257
MET DNA Alterations in NSCLC-Letter.
Mengoli MC, Bertolini F, Tiseo M, Barbieri F, Fiorentino M, Ardizzoni A, Rossi G. Mengoli MC, et al. Among authors: barbieri f. Clin Cancer Res. 2016 Jul 15;22(14):3697-8. doi: 10.1158/1078-0432.CCR-16-0351. Clin Cancer Res. 2016. PMID: 27422202 No abstract available.
684 results